EPIVIR

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug EPIVIR contains one active pharmaceutical ingredient (API):

1 Lamivudine UNII 2T8Q726O95 - LAMIVUDINE

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription. Read about Lamivudine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EPIVIR Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AF05	Lamivudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510602601117317, 510602602131313
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00728931, 02245585, 02699607, 03864149, 03882526, 04050845, 04764958, 05746141, 05907360, 07518467, 11220667
Country: EE	Ravimiamet	Identifier(s): 1025873, 1209697, 1209709
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 96015001, 96015002, 96015003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 101927, 101938, 101950
Country: FR	Base de données publique des médicaments	Identifier(s): 62715513, 64777862, 68036070
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26726, 26740, 26744
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3291, 3382, 4776
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250006F1031, 6250006F2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010269, 1010270, 1028025, 1028026, 1028027
Country: NL	Z-Index G-Standaard	Identifier(s): 14017385
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 44695, 44709, 59218
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100017240, 100087400, 100309645
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65301002, W65301003, W65302002, W65302003, W65303002
Country: SG	Health Sciences Authority	Identifier(s): 09134P, 09135P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 14293021H, 23013021
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522092666, 8699522592654
Country: US	FDA, National Drug Code	Identifier(s): 0173-0662, 0173-0663, 49702-203, 49702-204, 49702-205